novel approaches to treating mental health conditions

Enveric Biosciences is a biotechnology company dedicated to the development of novel small-molecule therapeutics for the treatment of anxiety, depression and addiction disorders

Management Team

Joseph Tucker, Ph.D.
Joseph
Tucker, Ph.D.

Chief Executive Officer, Director

Avani
Kanubaddi

President & COO

Bob
Dagher, M.D.

Chief Medical Officer

Peter
Facchini, Ph.D.

Chief Innovation Officer

Kevin
Coveney, CPA

Chief Financial Officer

Board of Directors

Michael D.
Webb

Board Chair

George
Kegler

Director, Chair of the Audit Committee

Douglas
Lind, M.D.

Director, Chair of the Nominating Committee

Bevin
O’Neil

Director

Frank
Pasqualone

Director, Chair of the Compensation Committee

Marcus
Schabacker, M.D., Ph.D.

Director

Joseph
Tucker, Ph.D.

Chief Executive Officer, Director

Scientific Advisors

Maurizio
Fava, M.D.

Scientific Advisor

Stephen M.
Stahl, M.D., Ph.D.

Scientific Advisor

Sheila
DeWitt, Ph.D.

Scientific Advisor

John
Krystal, M.D.

Scientific Advisor

Michael
Liebowitz, M.D.

Scientific Advisor

Discovering Next-generation Treatments for Mental Illness

Our mission is to pioneer a paradigm shift and generate new solutions with the potential to have profound effects on patients and their families, and to deliver life-changing medicines for diseases affecting the brain, such as anxiety, depression, and addiction.